▶ 調査レポート

オクスカルバゼピン薬の世界市場レポート2020

• 英文タイトル:Global Oxcarbazepine Drug Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。オクスカルバゼピン薬の世界市場レポート2020 / Global Oxcarbazepine Drug Sales Market Report 2020 / 20QY06-01218資料のイメージです。• レポートコード:20QY06-01218
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、144ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、オクスカルバゼピン薬のグローバル市場について種類別(タブレット、経口懸濁液)、用途別(成人、小児)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・オクスカルバゼピン薬市場の概要
・世界の主要地域別オクスカルバゼピン薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のオクスカルバゼピン薬市場規模2015-2026:種類別(タブレット、経口懸濁液)
・世界のオクスカルバゼピン薬市場規模2015-2026:用途別(成人、小児)
・オクスカルバゼピン薬の北米市場規模2015-2020
・オクスカルバゼピン薬のヨーロッパ市場規模2015-2020
・オクスカルバゼピン薬の中国市場規模2015-2020
・オクスカルバゼピン薬の日本市場規模2015-2020
・オクスカルバゼピン薬の東南アジア市場規模2015-2020
・オクスカルバゼピン薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Novartis、Supernus Pharmaceuticals、Apotex、West-Ward Pharmaceuticals、Taro Pharmaceuticals、Glenmark Pharmaceuticals、ANI Pharmaceuticals、Breckenridge Pharmaceutical、Amneal Pharmaceuticals、Teva、SihuanPharm、Humanwell)
・オクスカルバゼピン薬の製造コスト分析
・販売チャネル、流通業者、顧客
・オクスカルバゼピン薬の市場動向・機会・課題
・調査の結論

Oxcarbazepine is an anticonvulsant medication primarily used in the treatment of epilepsy. It may also be used as add-on therapy for bipolar disorder in people that have failed or are unable to tolerate other treatments.

Market Analysis and Insights: Global Oxcarbazepine Drug Market
The global Oxcarbazepine Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Oxcarbazepine Drug Scope and Market Size
The global Oxcarbazepine Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oxcarbazepine Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Oxcarbazepine Drug market is segmented into
Tablet
Oral suspension

Segment by Application, the Oxcarbazepine Drug market is segmented into
Adult
Pediatric
The Oxcarbazepine Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Oxcarbazepine Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oxcarbazepine Drug Market Share Analysis
Oxcarbazepine Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oxcarbazepine Drug business, the date to enter into the Oxcarbazepine Drug market, Oxcarbazepine Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Supernus Pharmaceuticals
Apotex
West-Ward Pharmaceuticals
Taro Pharmaceuticals
Glenmark Pharmaceuticals
ANI Pharmaceuticals
Breckenridge Pharmaceutical
Amneal Pharmaceuticals
Teva
SihuanPharm
Humanwell

レポート目次

Table of Contents

1 Oxcarbazepine Drug Market Overview
1.1 Oxcarbazepine Drug Product Scope
1.2 Oxcarbazepine Drug Segment by Type
1.2.1 Global Oxcarbazepine Drug Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Oral suspension
1.3 Oxcarbazepine Drug Segment by Application
1.3.1 Global Oxcarbazepine Drug Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Pediatric
1.4 Oxcarbazepine Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oxcarbazepine Drug Sales Growth Rate (2015-2026)
1.4.2 Global Oxcarbazepine Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Oxcarbazepine Drug Price Trends (2015-2026)

2 Oxcarbazepine Drug Estimate and Forecast by Region
2.1 Global Oxcarbazepine Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oxcarbazepine Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oxcarbazepine Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Oxcarbazepine Drug Revenue Market Share by Region (2015-2020)
2.3 Global Oxcarbazepine Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oxcarbazepine Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oxcarbazepine Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oxcarbazepine Drug Estimates and Projections (2015-2026)
2.4.2 Europe Oxcarbazepine Drug Estimates and Projections (2015-2026)
2.4.3 China Oxcarbazepine Drug Estimates and Projections (2015-2026)
2.4.4 Japan Oxcarbazepine Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oxcarbazepine Drug Estimates and Projections (2015-2026)
2.4.6 India Oxcarbazepine Drug Estimates and Projections (2015-2026)
3 Global Oxcarbazepine Drug Competition Landscape by Players
3.1 Global Top Oxcarbazepine Drug Players by Sales (2015-2020)
3.2 Global Top Oxcarbazepine Drug Players by Revenue (2015-2020)
3.3 Global Oxcarbazepine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxcarbazepine Drug as of 2019)
3.4 Global Oxcarbazepine Drug Average Price by Company (2015-2020)
3.5 Manufacturers Oxcarbazepine Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oxcarbazepine Drug Players (Opinion Leaders)
4 Global Oxcarbazepine Drug Market Size by Type
4.1 Global Oxcarbazepine Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Oxcarbazepine Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Oxcarbazepine Drug Price by Type (2014-2020)
4.2 Global Oxcarbazepine Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oxcarbazepine Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Oxcarbazepine Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Oxcarbazepine Drug Price Forecast by Type (2021-2026)
5 Global Oxcarbazepine Drug Market Size by Application
5.1 Global Oxcarbazepine Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Oxcarbazepine Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Oxcarbazepine Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Oxcarbazepine Drug Price by Application (2015-2020)
5.2 Global Oxcarbazepine Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oxcarbazepine Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Oxcarbazepine Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Oxcarbazepine Drug Price Forecast by Application (2021-2026)

3 North America Oxcarbazepine Drug Market Facts & Figures
3.2 North America Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
3.3 North America Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
3.4 North America Oxcarbazepine Drug Sales Market Share by Application (2015-2020)

4 Europe Oxcarbazepine Drug Market Facts & Figures
4.2 Europe Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
4.3 Europe Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
4.4 Europe Oxcarbazepine Drug Sales Market Share by Application (2015-2020)

5 China Oxcarbazepine Drug Market Facts & Figures
5.2 China Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
5.3 China Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
5.4 China Oxcarbazepine Drug Sales Market Share by Application (2015-2020)

6 Japan Oxcarbazepine Drug Market Facts & Figures
6.2 Japan Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
6.3 Japan Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
6.4 Japan Oxcarbazepine Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Oxcarbazepine Drug Market Facts & Figures
7.2 Southeast Asia Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Oxcarbazepine Drug Sales Market Share by Application (2015-2020)

8 India Oxcarbazepine Drug Market Facts & Figures
8.2 India Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
8.3 India Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
8.4 India Oxcarbazepine Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Oxcarbazepine Drug Business
12.1 Novartis
12.1.1 Novartis Oxcarbazepine Drug Corporation Information
12.1.2 Novartis Oxcarbazepine Drug Business Overview and Total Revenue
12.1.3 Novartis Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Oxcarbazepine Drug Products Offered
12.1.5 Novartis Recent Development
12.2 Supernus Pharmaceuticals
12.2.1 Supernus Pharmaceuticals Oxcarbazepine Drug Corporation Information
12.2.2 Supernus Pharmaceuticals Oxcarbazepine Drug Business Overview and Total Revenue
12.2.3 Supernus Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Supernus Pharmaceuticals Oxcarbazepine Drug Products Offered
12.2.5 Supernus Pharmaceuticals Recent Development
12.3 Apotex
12.3.1 Apotex Oxcarbazepine Drug Corporation Information
12.3.2 Apotex Oxcarbazepine Drug Business Overview and Total Revenue
12.3.3 Apotex Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Apotex Oxcarbazepine Drug Products Offered
12.3.5 Apotex Recent Development
12.4 West-Ward Pharmaceuticals
12.4.1 West-Ward Pharmaceuticals Oxcarbazepine Drug Corporation Information
12.4.2 West-Ward Pharmaceuticals Oxcarbazepine Drug Business Overview and Total Revenue
12.4.3 West-Ward Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 West-Ward Pharmaceuticals Oxcarbazepine Drug Products Offered
12.4.5 West-Ward Pharmaceuticals Recent Development
12.5 Taro Pharmaceuticals
12.5.1 Taro Pharmaceuticals Oxcarbazepine Drug Corporation Information
12.5.2 Taro Pharmaceuticals Oxcarbazepine Drug Business Overview and Total Revenue
12.5.3 Taro Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Taro Pharmaceuticals Oxcarbazepine Drug Products Offered
12.5.5 Taro Pharmaceuticals Recent Development
12.6 Glenmark Pharmaceuticals
12.6.1 Glenmark Pharmaceuticals Oxcarbazepine Drug Corporation Information
12.6.2 Glenmark Pharmaceuticals Oxcarbazepine Drug Business Overview and Total Revenue
12.6.3 Glenmark Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Glenmark Pharmaceuticals Oxcarbazepine Drug Products Offered
12.6.5 Glenmark Pharmaceuticals Recent Development
12.7 ANI Pharmaceuticals
12.7.1 ANI Pharmaceuticals Oxcarbazepine Drug Corporation Information
12.7.2 ANI Pharmaceuticals Oxcarbazepine Drug Business Overview and Total Revenue
12.7.3 ANI Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 ANI Pharmaceuticals Oxcarbazepine Drug Products Offered
12.7.5 ANI Pharmaceuticals Recent Development
12.8 Breckenridge Pharmaceutical
12.8.1 Breckenridge Pharmaceutical Oxcarbazepine Drug Corporation Information
12.8.2 Breckenridge Pharmaceutical Oxcarbazepine Drug Business Overview and Total Revenue
12.8.3 Breckenridge Pharmaceutical Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Breckenridge Pharmaceutical Oxcarbazepine Drug Products Offered
12.8.5 Breckenridge Pharmaceutical Recent Development
12.9 Amneal Pharmaceuticals
12.9.1 Amneal Pharmaceuticals Oxcarbazepine Drug Corporation Information
12.9.2 Amneal Pharmaceuticals Oxcarbazepine Drug Business Overview and Total Revenue
12.9.3 Amneal Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Amneal Pharmaceuticals Oxcarbazepine Drug Products Offered
12.9.5 Amneal Pharmaceuticals Recent Development
12.10 Teva
12.10.1 Teva Oxcarbazepine Drug Corporation Information
12.10.2 Teva Oxcarbazepine Drug Business Overview and Total Revenue
12.10.3 Teva Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Oxcarbazepine Drug Products Offered
12.10.5 Teva Recent Development
12.11 SihuanPharm
12.11.1 SihuanPharm Oxcarbazepine Drug Corporation Information
12.11.2 SihuanPharm Oxcarbazepine Drug Business Overview and Total Revenue
12.11.3 SihuanPharm Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 SihuanPharm Oxcarbazepine Drug Products Offered
12.11.5 SihuanPharm Recent Development
12.12 Humanwell
12.12.1 Humanwell Oxcarbazepine Drug Corporation Information
12.12.2 Humanwell Oxcarbazepine Drug Business Overview and Total Revenue
12.12.3 Humanwell Oxcarbazepine Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Humanwell Oxcarbazepine Drug Products Offered
12.12.5 Humanwell Recent Development

13 Oxcarbazepine Drug Manufacturing Cost Analysis
13.1 Oxcarbazepine Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oxcarbazepine Drug
13.4 Oxcarbazepine Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oxcarbazepine Drug Distributors List
14.3 Oxcarbazepine Drug Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Oxcarbazepine Drug Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Oxcarbazepine Drug Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Oxcarbazepine Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Oxcarbazepine Drug Sales (K MT) by Region (2015-2020)
Table 5. Global Oxcarbazepine Drug Sales Market Share by Region (2015-2020)
Table 6. Global Oxcarbazepine Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Oxcarbazepine Drug Revenue Share by Region (2015-2020)
Table 8. Global Oxcarbazepine Drug Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Oxcarbazepine Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Oxcarbazepine Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Oxcarbazepine Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Oxcarbazepine Drug (K MT) of Key Companies (2015-2020)
Table 13. Global Oxcarbazepine Drug Sales Share by Company (2015-2020)
Table 14. Global Oxcarbazepine Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Oxcarbazepine Drug Revenue Share by Company (2015-2020)
Table 16. Global Oxcarbazepine Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxcarbazepine Drug as of 2019)
Table 17. Global Oxcarbazepine Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Oxcarbazepine Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Oxcarbazepine Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Oxcarbazepine Drug Players
Table 22. Global Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 23. Global Oxcarbazepine Drug Sales Share by Type (2015-2020)
Table 24. Global Oxcarbazepine Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Oxcarbazepine Drug Price (K MT) by Type (2015-2020)
Table 26. Global Oxcarbazepine Drug Sales Share by Type (2021-2026)
Table 27. Global Oxcarbazepine Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Oxcarbazepine Drug Revenue Share by Type (2021-2026)
Table 29. Global Oxcarbazepine Drug Price (K MT) by Type (2021-2026)
Table 30. Global Oxcarbazepine Drug Sales (K MT) by Application (2015-2020)
Table 31. Global Oxcarbazepine Drug Sales Share by Application (2015-2020)
Table 32. Global Oxcarbazepine Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Oxcarbazepine Drug Price (K MT) by Application (2015-2020)
Table 34. Global Oxcarbazepine Drug Sales (K MT) by Application (2021-2026)
Table 35. Global Oxcarbazepine Drug Sales Share by Application (2021-2026)
Table 36. Global Oxcarbazepine Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Oxcarbazepine Drug Revenue Share by Application (2021-2026)
Table 38. Global Oxcarbazepine Drug Price (K MT) by Application (2021-2026)
Table 39. United States Oxcarbazepine Drug Sales (K MT) by Company (2015-2020)
Table 40. United States Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
Table 41. United States Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
Table 43. United States Oxcarbazepine Drug Sales (K MT) by Application (2015-2020)
Table 44. United States Oxcarbazepine Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Oxcarbazepine Drug Sales (K MT) by Company (2015-2020)
Table 46. Europe Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 48. Europe Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Oxcarbazepine Drug Sales (K MT) by Application (2015-2020)
Table 50. Europe Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
Table 51. China Oxcarbazepine Drug Sales (K MT) by Company (2015-2020)
Table 52. China Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
Table 53. China Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 54. China Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
Table 55. China Oxcarbazepine Drug Sales (K MT) by Application (2015-2020)
Table 56. China Oxcarbazepine Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Oxcarbazepine Drug Sales (K MT) by Company (2015-2020)
Table 58. Japan Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 60. Japan Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Oxcarbazepine Drug Sales (K MT) by Application (2015-2020)
Table 62. Japan Oxcarbazepine Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Oxcarbazepine Drug Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Oxcarbazepine Drug Sales Market Share by Application (2015-2020)
Table 69. India Oxcarbazepine Drug Sales (K MT) by Company (2015-2020)
Table 70. India Oxcarbazepine Drug Sales Market Share by Company (2015-2020)
Table 71. India Oxcarbazepine Drug Sales (K MT) by Type (2015-2020)
Table 72. India Oxcarbazepine Drug Sales Market Share by Type (2015-2020)
Table 73. India Oxcarbazepine Drug Sales (K MT) by Application (2015-2020)
Table 74. India Oxcarbazepine Drug Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novartis Oxcarbazepine Drug Product
Table 79. Novartis Recent Development
Table 80. Supernus Pharmaceuticals Corporation Information
Table 81. Supernus Pharmaceuticals Description and Business Overview
Table 82. Supernus Pharmaceuticals Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Supernus Pharmaceuticals Oxcarbazepine Drug Product
Table 84. Supernus Pharmaceuticals Recent Development
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Apotex Oxcarbazepine Drug Product
Table 89. Apotex Recent Development
Table 90. West-Ward Pharmaceuticals Corporation Information
Table 91. West-Ward Pharmaceuticals Description and Business Overview
Table 92. West-Ward Pharmaceuticals Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. West-Ward Pharmaceuticals Oxcarbazepine Drug Product
Table 94. West-Ward Pharmaceuticals Recent Development
Table 95. Taro Pharmaceuticals Corporation Information
Table 96. Taro Pharmaceuticals Description and Business Overview
Table 97. Taro Pharmaceuticals Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Taro Pharmaceuticals Oxcarbazepine Drug Product
Table 99. Taro Pharmaceuticals Recent Development
Table 100. Glenmark Pharmaceuticals Corporation Information
Table 101. Glenmark Pharmaceuticals Description and Business Overview
Table 102. Glenmark Pharmaceuticals Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Glenmark Pharmaceuticals Oxcarbazepine Drug Product
Table 104. Glenmark Pharmaceuticals Recent Development
Table 105. ANI Pharmaceuticals Corporation Information
Table 106. ANI Pharmaceuticals Description and Business Overview
Table 107. ANI Pharmaceuticals Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. ANI Pharmaceuticals Oxcarbazepine Drug Product
Table 109. ANI Pharmaceuticals Recent Development
Table 110. Breckenridge Pharmaceutical Corporation Information
Table 111. Breckenridge Pharmaceutical Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Breckenridge Pharmaceutical Description and Business Overview
Table 113. Breckenridge Pharmaceutical Oxcarbazepine Drug Product
Table 114. Breckenridge Pharmaceutical Recent Development
Table 115. Amneal Pharmaceuticals Corporation Information
Table 116. Amneal Pharmaceuticals Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Amneal Pharmaceuticals Description and Business Overview
Table 118. Amneal Pharmaceuticals Oxcarbazepine Drug Product
Table 119. Amneal Pharmaceuticals Recent Development
Table 120. Teva Corporation Information
Table 121. Teva Description and Business Overview
Table 122. Teva Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Teva Oxcarbazepine Drug Product
Table 124. Teva Recent Development
Table 125. SihuanPharm Corporation Information
Table 126. SihuanPharm Description and Business Overview
Table 127. SihuanPharm Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. SihuanPharm Oxcarbazepine Drug Product
Table 129. SihuanPharm Recent Development
Table 130. Humanwell Corporation Information
Table 131. Humanwell Description and Business Overview
Table 132. Humanwell Oxcarbazepine Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Humanwell Oxcarbazepine Drug Product
Table 134. Humanwell Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Oxcarbazepine Drug Distributors List
Table 138. Oxcarbazepine Drug Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxcarbazepine Drug Product Picture
Figure 2. Global Oxcarbazepine Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oxcarbazepine Drug Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Pediatric Examples
Figure 8. Global Oxcarbazepine Drug Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Oxcarbazepine Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Oxcarbazepine Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Oxcarbazepine Drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Oxcarbazepine Drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Oxcarbazepine Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Oxcarbazepine Drug Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Oxcarbazepine Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Oxcarbazepine Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Oxcarbazepine Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Oxcarbazepine Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Oxcarbazepine Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Oxcarbazepine Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Oxcarbazepine Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Oxcarbazepine Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Oxcarbazepine Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Oxcarbazepine Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Oxcarbazepine Drug Players Market Share by Revenue in Oxcarbazepine Drug 2015 & 2019
Figure 26. Oxcarbazepine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Oxcarbazepine Drug Revenue Share by Type (2015-2020)
Figure 28. Global Oxcarbazepine Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Oxcarbazepine Drug Revenue Share by Application (2015-2020)
Figure 30. Global Oxcarbazepine Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Oxcarbazepine Drug Sales Market Share by Type in 2019
Figure 32. United States Oxcarbazepine Drug Sales Market Share by Type in 2019
Figure 33. Europe Oxcarbazepine Drug Sales Market Share by Company in 2019
Figure 34. Europe Oxcarbazepine Drug Sales Market Share by Type in 2019
Figure 35. Europe Oxcarbazepine Drug Sales Market Share by Application in 2019
Figure 36. China Oxcarbazepine Drug Sales Market Share by Company in 2019
Figure 37. China Oxcarbazepine Drug Sales Market Share by Type in 2019
Figure 38. China Oxcarbazepine Drug Sales Market Share by Application in 2019
Figure 39. Japan Oxcarbazepine Drug Sales Market Share by Company in 2019
Figure 40. Japan Oxcarbazepine Drug Sales Market Share by Type in 2019
Figure 41. Japan Oxcarbazepine Drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Oxcarbazepine Drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Oxcarbazepine Drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Oxcarbazepine Drug Sales Market Share by Application in 2019
Figure 45. India Oxcarbazepine Drug Sales Market Share by Company in 2019
Figure 46. India Oxcarbazepine Drug Sales Market Share by Type in 2019
Figure 47. India Oxcarbazepine Drug Sales Market Share by Application in 2019
Figure 48. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Supernus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. West-Ward Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Taro Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. ANI Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Breckenridge Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. SihuanPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Humanwell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Oxcarbazepine Drug
Figure 62. Manufacturing Process Analysis of Oxcarbazepine Drug
Figure 63. Oxcarbazepine Drug Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed